TY - JOUR
T1 - The prevalence of meticillin-resistant Staphylococcus aureus in long-term care facilities
T2 - Is there a need for tailored glycopeptide prophylaxis?
AU - Hennessey, D.
AU - Green, C.
AU - Fitzpatrick, C.
AU - Fenelon, L.
AU - O'Rourke, K.
PY - 2010
Y1 - 2010
N2 - Prophylactic antibiotics are effective in reducing the rate of surgical site infection (SSI). Cephalosporin antibiotics are recommended except for patients colonised with meticillin resistant staphylococcus aureus (MRSA), where glycopeptide antibiotics are indicated. However, in the trauma setting, the MRSA status is unknown prior to surgery. Aim: To determine if the incidence of MRSA colonisation in trauma patients from long term care (LTC) warrants the use of empirical glycopeptide antibiotics. Methods: A retrospective analysis of patients admitted with hip fractures was performed. The MRSA status of patient from LTC facilities and home was determined. Results: The prevalence of MRSA colonisation in patients admitted from LTC facilities was 33.6%, compared to 3.6% for patients admitted from home, P < 0.001. Our results suggest that risk of patients carrying MRSA is significantly higher for patients being admitted form LTC. This group of patients may benefit from empirical glycopeptide antibiotic when the MRSA status is unknown.
AB - Prophylactic antibiotics are effective in reducing the rate of surgical site infection (SSI). Cephalosporin antibiotics are recommended except for patients colonised with meticillin resistant staphylococcus aureus (MRSA), where glycopeptide antibiotics are indicated. However, in the trauma setting, the MRSA status is unknown prior to surgery. Aim: To determine if the incidence of MRSA colonisation in trauma patients from long term care (LTC) warrants the use of empirical glycopeptide antibiotics. Methods: A retrospective analysis of patients admitted with hip fractures was performed. The MRSA status of patient from LTC facilities and home was determined. Results: The prevalence of MRSA colonisation in patients admitted from LTC facilities was 33.6%, compared to 3.6% for patients admitted from home, P < 0.001. Our results suggest that risk of patients carrying MRSA is significantly higher for patients being admitted form LTC. This group of patients may benefit from empirical glycopeptide antibiotic when the MRSA status is unknown.
UR - http://www.scopus.com/inward/record.url?scp=77956454362&partnerID=8YFLogxK
U2 - 10.1177/1757177410375487
DO - 10.1177/1757177410375487
M3 - Article
AN - SCOPUS:77956454362
SN - 1757-1774
VL - 11
SP - 161
EP - 165
JO - Journal of Infection Prevention
JF - Journal of Infection Prevention
IS - 5
ER -